查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1460701

皮肤荨麻疹治疗市场 - 全球产业规模、份额、趋势、机会和预测，按类型、治疗、给药途径、配销通路、地区和竞争细分，2019-2029F

Skin Hives Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type, By Treatment, By Route of Administration, By Distribution Channel, By Region and Competition, 2019-2029F
出版日期: | 出版商: TechSci Research | 英文 180 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

2023 年，全球皮肤荨麻疹治疗市场估值为 27.5 亿美元，预计在预测期内将出现令人印象深刻的成长，到 2029 年CAGR为8.05%。在各种因素的推动下，皮肤荨麻疹治疗市场正在见证显着的成长和演变，共同为其扩张和多元化做出贡献。皮肤荨麻疹，也称为荨麻疹，是一种常见的过敏性皮肤病，其特征是皮肤上出现红色、发痒的伤痕或凸起的肿块，通常是由对某些食物、药物、昆虫叮咬或环境因素的过敏反应引发的。由于全球过敏性疾病发生率不断上升，每年有数百万人受到荨麻疹的影响，皮肤荨麻疹治疗市场成长动能强劲。

推动皮肤荨麻疹治疗市场的主要动力之一是皮肤荨麻疹疾病的盛行率不断增加。近年来，过敏变得越来越普遍，影响所有年龄和背景的人。皮肤荨麻疹是最明显、最令人不适的过敏反应之一，促使患者立即寻求缓解，从而推动了对有效治疗方案的需求。推动市场成长的另一个关键因素是对快速有效的缓解药物的需求不断增长。患有急性荨麻疹发作的患者经常会出现剧烈的搔痒、肿胀和不适，需要立即采取可靠的治疗方法。因此，製药公司正在投资研发，以配製速效且持久的药物，包括抗组织胺、皮质类固醇和肾上腺素注射器，以快速缓解荨麻疹患者的症状。

医学研究和技术的进步在塑造皮肤荨麻疹治疗市场方面也发挥关键作用。正在进行的研究工作重点是了解荨麻疹的根本原因，包括免疫系统异常和遗传倾向。这种深入的知识有助于开发针对特定荨麻疹触发因素和患者概况的标靶疗法、个人化治疗计划和新型药物。因此，市场见证了创新和更有效的治疗方案的推出，确保更好的结果并提高患者的生活品质。此外，医疗保健专业人员和一般大众对皮肤荨麻疹及其诱因的认识不断增强。医疗专业人员越来越认识到可能导致荨麻疹的多种因素，使他们能够提供准确的诊断和适当的治疗。此外，公众意识活动、教育措施和线上资源使个人能够识别荨麻疹症状、及时寻求医疗建议并遵守处方治疗，从而推动了对荨麻疹治疗解决方案的需求。

除了传统的药物干预措施外，人们对皮肤荨麻疹整体和自然疗法的兴趣和投资也在增加。草药疗法、饮食调整、压力管理技术和针灸等替代疗法在寻求自然和非侵入性解决方案来控制荨麻疹症状的个人中越来越受欢迎。这一趋势使皮肤荨麻疹治疗市场多样化，提供了广泛的选择，以满足患者对医疗保健的不同偏好和信念。总之，皮肤荨麻疹治疗市场的特征是医疗进步、患者意识和不断发展的治疗方式相互作用形成的动态格局。随着皮肤荨麻疹疾病的日益流行，加上对快速缓解和个人化治疗的需求，市场有望持续成长和创新。随着研究不断发现对荨麻疹触发因素和机制的新见解，市场预计将见证先进疗法的推出，确保更好的症状管理并提高受这种常见过敏性疾病影响的个人的生活品质。

主要市场驱动因素

人们对皮肤荨麻疹的认识不断提高

目录

第 1 章：产品概述

第 2 章：研究方法

第 3 章：执行摘要

第 4 章：全球皮肤荨麻疹治疗市场展望

  • 市场规模预测
    • 按价值
  • 市占率预测
    • 依类型（慢性荨麻疹、急性荨麻疹）
    • 依治疗方法（抗发炎药、止痒药、抗组织胺、其他）
    • 依给药途径（口服、局部、肠胃外）
    • 按配销通路（医院药房、网路药房、零售药房）
    • 按地区
    • 按公司划分 (2023)
  • 市场地图
    • 按类型
    • 按治疗
    • 依给药途径
    • 按配销通路
    • 按地区

第 5 章：亚太地区皮肤荨麻疹治疗市场展望

  • 市场规模预测
    • 按价值
  • 市占率预测
    • 按类型
    • 按治疗
    • 依给药途径
    • 按配销通路
    • 按国家/地区
  • 亚太地区：国家分析
    • 中国
    • 印度
    • 澳洲
    • 日本
    • 韩国

第 6 章：欧洲皮肤荨麻疹治疗市场展望

  • 市场规模预测
    • 按价值
  • 市占率预测
    • 按类型
    • 按治疗
    • 依给药途径
    • 按配销通路
    • 按国家/地区
  • 欧洲：国家分析
    • 法国
    • 德国
    • 西班牙
    • 义大利
    • 英国

第 7 章：北美皮肤荨麻疹治疗市场展望

  • 市场规模预测
    • 按价值
  • 市占率预测
    • 按类型
    • 按治疗
    • 依给药途径
    • 按配销通路
    • 按国家/地区
  • 北美：国家分析
    • 美国
    • 墨西哥
    • 加拿大

第 8 章：南美洲皮肤荨麻疹治疗市场展望

  • 市场规模预测
    • 按价值
  • 市占率预测
    • 按类型
    • 按治疗
    • 依给药途径
    • 按配销通路
    • 按国家/地区
  • 南美洲：国家分析
    • 巴西
    • 阿根廷
    • 哥伦比亚

第 9 章：中东和非洲皮肤荨麻疹治疗市场展望

  • 市场规模预测
    • 按价值
  • 市占率预测
    • 按类型
    • 按治疗
    • 依给药途径
    • 按配销通路
    • 按国家/地区
  • MEA：国家分析
    • 南非
    • 沙乌地阿拉伯
    • 阿联酋

第 10 章：市场动态

  • 司机
  • 挑战

第 11 章：市场趋势发展

  • 最近的发展
  • 产品发布
  • 併购

第 12 章：全球皮肤荨麻疹治疗市场：SWOT 分析

第 13 章：波特的五力分析

  • 产业竞争
  • 新进入者的潜力
  • 供应商的力量
  • 客户的力量
  • 替代产品的威胁

第14章：竞争格局

  • Otsuka Holdings Co., Ltd
  • 大鹏製药株式会社
  • Amneal 製药股份有限公司
  • 高德美公司
  • F.霍夫曼-拉罗氏股份公司
  • 诺华公司
  • 雷迪博士实验室有限公司
  • 格兰马克製药有限公司
  • 赛诺菲公司

第 15 章：策略建议

第 16 章：关于我们免责声明

简介目录
Product Code: 22717

Global Skin Hives Treatment Market was valued at USD 2.75 Billion in 2023 and is anticipated to project impressive growth in the forecast period with a CAGR of 8.05% through 2029. The Skin Hives Treatment Market is witnessing significant growth and evolution, driven by various factors that collectively contribute to its expansion and diversification. Skin hives, also known as urticaria, is a common allergic skin condition characterized by red, itchy welts or raised bumps on the skin, often triggered by allergic reactions to certain foods, medications, insect bites, or environmental factors. The market for skin hives treatment has gained momentum due to the rising incidence of allergic disorders globally, with millions of people affected by hives each year.

One of the primary drivers fueling the Skin Hives Treatment Market is the increasing prevalence of skin hives disorders. Allergies have become more common in recent years, affecting individuals of all ages and backgrounds. Skin hives, being one of the most visible and discomforting allergic reactions, prompt patients to seek immediate relief, driving the demand for effective treatment options. Another key factor propelling the market growth is the growing demand for quick and efficient relief medications. Patients suffering from acute hives episodes often experience intense itching, swelling, and discomfort, necessitating immediate and reliable remedies. Consequently, pharmaceutical companies are investing in research and development to formulate fast-acting and long-lasting medications, including antihistamines, corticosteroids, and epinephrine injectors, to provide rapid relief to patients experiencing hives.

Advancements in medical research and technology also play a pivotal role in shaping the Skin Hives Treatment Market. Ongoing research efforts focus on understanding the underlying causes of hives, including immune system abnormalities and genetic predispositions. This in-depth knowledge enables the development of targeted therapies, personalized treatment plans, and novel medications tailored to specific hives triggers and patient profiles. As a result, the market witnesses the introduction of innovative and more effective treatment options, ensuring better outcomes and improved quality of life for patients. Furthermore, there is a growing awareness about skin hives and its triggers among both healthcare professionals and the general population. Medical professionals are increasingly recognizing the diverse range of factors that can lead to hives, enabling them to provide accurate diagnoses and appropriate treatments. Additionally, public awareness campaigns, educational initiatives, and online resources have empowered individuals to identify hives symptoms, seek timely medical advice, and adhere to prescribed treatments, thereby driving the demand for hives treatment solutions.

In addition to conventional pharmaceutical interventions, there is a rise in interest and investment in holistic and natural approaches to skin hives treatment. Herbal remedies, dietary modifications, stress management techniques, and alternative therapies like acupuncture are gaining popularity among individuals seeking natural and non-invasive solutions for managing hives symptoms. This trend diversifies the Skin Hives Treatment Market, offering a wide array of options catering to patients' varying preferences and beliefs regarding healthcare. In conclusion, the Skin Hives Treatment Market is characterized by a dynamic landscape shaped by the interplay of medical advancements, patient awareness, and evolving treatment modalities. With the increasing prevalence of skin hives disorders, coupled with the demand for quick relief and personalized treatments, the market is poised for continuous growth and innovation. As research continues to uncover new insights into hives triggers and mechanisms, the market is expected to witness the introduction of advanced therapies, ensuring better symptom management and improved quality of life for individuals affected by this common allergic condition.

Key Market Drivers

Rising awareness about skin hives

The rising awareness about skin hives is a significant driving force behind the Skin Hives Treatment Market. Increased public knowledge about hives symptoms, triggers, and available treatment options has led to early diagnosis and proactive healthcare-seeking behavior. This heightened awareness not only empowers individuals to recognize hives but also encourages them to seek timely medical intervention. Healthcare professionals are better equipped to provide accurate diagnoses and recommend suitable treatments, fostering a more informed patient population. Consequently, the growing awareness has led to a higher demand for hives treatments, driving market growth as pharmaceutical companies develop innovative solutions to meet the needs of an increasingly knowledgeable and proactive patient base.

Innovative treatment options

Innovative treatment options are fueling the growth of the Skin Hives Treatment Market by revolutionizing the management of hives. Pharmaceutical advancements, including novel antihistamines, immune modulators, and targeted therapies, are providing more efficient and tailored solutions. Personalized medicine, backed by genetic research, enables specific treatments addressing individual triggers and symptoms, enhancing efficacy. Additionally, research into holistic approaches, such as herbal remedies and lifestyle modifications, is diversifying the market, catering to diverse patient preferences. These innovations not only improve symptom relief but also minimize side effects, elevating the overall quality of care. As patients and healthcare professionals increasingly embrace these progressive treatments, the market continues to expand, meeting the evolving needs of hives sufferers worldwide.

Key Market Challenges

Diverse Triggers

The diverse range of triggers for skin hives poses a significant challenge for the Skin Hives Treatment Market. Hives can be caused by numerous factors, including allergies, stress, infections, or medications, making it challenging to identify the specific cause in individual patients. This complexity hampers the development of universal treatment approaches, as therapies need to be tailored to address different triggers effectively. Healthcare professionals face the daunting task of conducting extensive diagnostic assessments to pinpoint the underlying cause accurately. Moreover, the variability in triggers necessitates a multifaceted treatment approach, increasing the complexity of designing comprehensive and targeted treatments, thereby posing a challenge for pharmaceutical companies and researchers striving to develop effective solutions for hives sufferers.

Chronic Nature

The chronic nature of skin hives presents a significant challenge for the Skin Hives Treatment Market. Hives often recur intermittently over an extended period, requiring continuous management and treatment. This chronicity places a substantial burden on patients, impacting their quality of life and necessitating long-term medical intervention. Moreover, the need for sustained treatment complicates healthcare providers' efforts to design effective and patient-friendly regimens. Pharmaceutical companies face the challenge of developing therapies that provide enduring relief without adverse side effects, making research and innovation crucial. The chronic nature of hives emphasizes the market's necessity for durable and efficient treatment options, demanding ongoing efforts to address the evolving needs of patients facing this persistent condition.

Limited Efficacy

The limited efficacy of existing treatments poses a significant challenge for the Skin Hives Treatment Market. While various medications are available, they do not guarantee complete relief for all patients. Some individuals may experience only partial symptom alleviation or no improvement at all, leading to frustration and dissatisfaction. This inconsistency in treatment outcomes highlights the need for more effective therapies. Pharmaceutical companies and researchers face the daunting task of developing innovative treatments that offer comprehensive relief, addressing the underlying causes of hives. Overcoming this challenge requires continued investment in research and development to create advanced, targeted therapies capable of providing consistent and substantial relief for individuals afflicted with skin hives.

Individual Variability

Individual variability presents a significant challenge for the Skin Hives Treatment Market. Patients with skin hives often respond differently to various treatments due to their unique genetic makeup, underlying health conditions, and specific triggers. This diversity in individual responses complicates the development of standardized treatment protocols. Tailoring therapies to suit each patient's specific needs is essential, demanding personalized approaches that can address the variability in symptoms and triggers. Healthcare providers face the challenge of determining the most effective treatment for each patient, emphasizing the necessity for precision medicine in hives management. Overcoming this challenge requires innovative research, advanced diagnostic tools, and the development of customizable therapies to cater to the diverse responses among hives sufferers.

Key Market Trends

Personalized Medicine

Personalized medicine stands out as a key trend in the Skin Hives Treatment Market, revolutionizing how hives are managed. By tailoring treatments based on patients' genetic makeup, lifestyle, and triggers, personalized medicine ensures more precise and effective interventions. Advanced diagnostic techniques enable healthcare providers to identify specific markers and triggers unique to each patient, allowing for targeted therapies. This approach minimizes trial-and-error in treatment, enhancing efficacy while reducing adverse effects. Pharmaceutical companies and researchers are increasingly investing in this approach, developing therapies that cater to individual variations. Personalized medicine not only improves patient outcomes but also represents a paradigm shift, offering a more patient-centric and efficient approach to addressing the complexities of skin hives.

Immunotherapy Advancements

Immunotherapy advancements are a prominent trend in the Skin Hives Treatment Market, offering innovative solutions for patients. By harnessing the body's immune system to target hives triggers, immunotherapy presents a promising avenue for more effective and lasting relief. Ongoing research focuses on immune modulators, allergen-specific immunotherapy, and biologics, aiming to enhance the body's response to allergens and reduce hives symptoms. These developments signify a shift toward treatments addressing the root cause of hives, rather than just managing symptoms. As clinical trials yield positive results, immunotherapy options are expanding, providing new hope for patients and reshaping the landscape of hives treatment with cutting-edge, immune-focused therapies.

Natural and Holistic Approaches

Natural and holistic approaches are emerging as a significant trend in the Skin Hives Treatment Market. Increasingly, patients are seeking alternative therapies, such as herbal remedies, dietary modifications, stress management techniques, and acupuncture, to manage hives symptoms. These approaches offer non-invasive, side-effect-free options, aligning with the growing preference for natural healthcare solutions. Additionally, research into the impact of lifestyle factors, such as diet and stress, on hives occurrence, is gaining traction. Pharmaceutical companies and healthcare providers are recognizing the importance of integrating these holistic approaches into conventional treatments, offering a comprehensive and patient-centered approach to hives management. This trend reflects the market's response to the demand for more diverse and holistic hives treatment options, catering to patients' individual preferences and well-being.

Research into Genetic Triggers

Research into genetic triggers has emerged as a pivotal trend in the Skin Hives Treatment Market, revolutionizing hives management. Scientists are delving deep into the genetic factors underlying hives, aiming to identify specific genetic markers and pathways responsible for triggering allergic reactions. This in-depth understanding enables the development of targeted therapies tailored to individual patients, addressing the root cause of hives at a molecular level. Precision medicine, guided by genetic insights, is reshaping treatment protocols, ensuring more effective and personalized interventions. Pharmaceutical companies are investing significantly in genetic research, leading to the creation of innovative therapies that offer precise, genetics-based solutions. This trend signifies a paradigm shift towards advanced, genetics-driven hives treatments, promising enhanced outcomes and improved quality of life for patients.

Segmental Insights

Treatment Insights

Basedon the Treatment, Antihistamines have long been the dominant force in the Skin Hives Treatment Market. These medications effectively block histamine, the chemical responsible for hives symptoms, providing relief from itching, swelling, and discomfort. Available in various forms (prescription and over the counter), antihistamines are widely accessible and commonly prescribed by healthcare providers. While newer therapies and holistic approaches are gaining ground, antihistamines remain the go-to option for managing acute hives episodes. Their proven efficacy, ease of use, and familiarity among both patients and physicians have sustained their dominance. However, the market is evolving with ongoing research, emphasizing the need for a diversified approach that integrates antihistamines with innovative treatments to offer comprehensive solutions for hives sufferers.

Route of Administration Insights

Oral medications have established dominance in the Skin Hives Treatment Market due to their convenience, effectiveness, and ease of administration. Oral antihistamines, corticosteroids, and other systemic medications offer a systemic approach to hives management, providing relief from itching, swelling, and discomfort throughout the body. Their oral form ensures patient compliance, making them a preferred choice for both acute and chronic hives. Moreover, oral medications are easily accessible, available in various formulations, and can be prescribed at different dosage strengths, allowing for personalized treatment plans. This convenience factor, coupled with their proven efficacy, has solidified oral medications' dominance, making them the primary choice for healthcare providers and patients alike in the treatment of skin hives.

Regional Insights

North America stands as the dominant force in the Skin Hives Treatment Market due to several factors. The region boasts advanced healthcare infrastructure, extensive research and development activities, and high healthcare spending, fostering the development of innovative treatments. Additionally, a well-established pharmaceutical industry and a large patient population with allergic conditions contribute to market growth. Moreover, widespread awareness about skin hives, easy accessibility to healthcare services, and favorable reimbursement policies enhance the market's prominence. Collaborations between pharmaceutical companies, research institutions, and healthcare providers further drive advancements. These factors combined establish North America as a leading hub for skin hives treatment, shaping the market's trends and developments.

Key Market Players

Otsuka Holdings Co., Ltd

Taiho Pharmaceutical Co., Ltd

Amneal Pharmaceuticals LLC

Galderma SA

F. Hoffmann-La Roche AG

Novartis AG

Dr. Reddy's Laboratories Ltd.

Glenmark Pharmaceuticals Ltd.

Sanofi SA

Report Scope:

In this report, the Global Skin Hives Treatment Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Skin Hives Treatment Market,By Type:

  • Chronic Hives
  • Acute Hives

Skin Hives Treatment Market,By Treatment:

  • Anti-Inflammatory Drugs
  • Anti-Itch Drugs
  • Antihistamines
  • Others

Skin Hives Treatment Market,By Route of Administration:

  • Oral
  • Topical
  • Parenteral

Skin Hives Treatment Market,By Distribution Channel:

  • Hospital Pharmacies
  • Online Pharmacies
  • Retail Pharmacies

Skin Hives Treatment Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Skin Hives Treatment Market.

Available Customizations:

Global Skin Hives Treatment market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1.Product Overview

  • 1.1.Market Definition
  • 1.2.Scope of the Market
    • 1.2.1.Markets Covered
    • 1.2.2.Years Considered for Study
    • 1.2.3.Key Market Segmentations

2.Research Methodology

  • 2.1.Objective of the Study
  • 2.2.Baseline Methodology
  • 2.3.Key Industry Partners
  • 2.4.Major Association and Secondary Sources
  • 2.5.Forecasting Methodology
  • 2.6.Data Triangulation Validation
  • 2.7.Assumptions and Limitations

3.Executive Summary

  • 3.1.Overview of the Market
  • 3.2.Overview of Key Market Segmentations
  • 3.3.Overview of Key Market Players
  • 3.4.Overview of Key Regions/Countries
  • 3.5.Overview of Market Drivers, Challenges, Trends

4.Global Skin Hives Treatment Market Outlook

  • 4.1.Market Size Forecast
    • 4.1.1.By Value
  • 4.2.Market Share Forecast
    • 4.2.1.By Type (Chronic Hives, Acute Hives)
    • 4.2.2.By Treatment (Anti-Inflammatory Drugs, Anti-Itch Drugs, Antihistamines, Others)
    • 4.2.3.By Route of Administration (Oral, Topical, Parenteral)
    • 4.2.4.By Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies)
    • 4.2.5.By Region
    • 4.2.6.By Company (2023)
  • 4.3.Market Map
    • 4.3.1.By Type
    • 4.3.2.By Treatment
    • 4.3.3.By Route of Administration
    • 4.3.4.By Distribution Channel
    • 4.3.5.By Region

5.Asia Pacific Skin Hives Treatment Market Outlook

  • 5.1.Market Size Forecast
    • 5.1.1.By Value
  • 5.2.Market Share Forecast
    • 5.2.1.By Type
    • 5.2.2.By Treatment
    • 5.2.3.By Route of Administration
    • 5.2.4.By Distribution Channel
    • 5.2.5.By Country
  • 5.3.Asia Pacific: Country Analysis
    • 5.3.1.China Skin Hives Treatment Market Outlook
      • 5.3.1.1.Market Size Forecast
        • 5.3.1.1.1.By Value
      • 5.3.1.2.Market Share Forecast
        • 5.3.1.2.1.By Type
        • 5.3.1.2.2.By Treatment
        • 5.3.1.2.3.By Route of Administration
        • 5.3.1.2.4.By Distribution Channel
    • 5.3.2.India Skin Hives Treatment Market Outlook
      • 5.3.2.1.Market Size Forecast
        • 5.3.2.1.1.By Value
      • 5.3.2.2.Market Share Forecast
        • 5.3.2.2.1.By Type
        • 5.3.2.2.2.By Treatment
        • 5.3.2.2.3.By Route of Administration
        • 5.3.2.2.4.By Distribution Channel
    • 5.3.3.Australia Skin Hives Treatment Market Outlook
      • 5.3.3.1.Market Size Forecast
        • 5.3.3.1.1.By Value
      • 5.3.3.2.Market Share Forecast
        • 5.3.3.2.1.By Type
        • 5.3.3.2.2.By Treatment
        • 5.3.3.2.3.By Route of Administration
        • 5.3.3.2.4.By Distribution Channel
    • 5.3.4.Japan Skin Hives Treatment Market Outlook
      • 5.3.4.1.Market Size Forecast
        • 5.3.4.1.1.By Value
      • 5.3.4.2.Market Share Forecast
        • 5.3.4.2.1.By Type
        • 5.3.4.2.2.By Treatment
        • 5.3.4.2.3.By Route of Administration
        • 5.3.4.2.4.By Distribution Channel
    • 5.3.5.South Korea Skin Hives Treatment Market Outlook
      • 5.3.5.1.Market Size Forecast
        • 5.3.5.1.1.By Value
      • 5.3.5.2.Market Share Forecast
        • 5.3.5.2.1.By Type
        • 5.3.5.2.2.By Treatment
        • 5.3.5.2.3.By Route of Administration
        • 5.3.5.2.4.By Distribution Channel

6.Europe Skin Hives Treatment Market Outlook

  • 6.1.Market Size Forecast
    • 6.1.1.By Value
  • 6.2.Market Share Forecast
    • 6.2.1.By Type
    • 6.2.2.By Treatment
    • 6.2.3.By Route of Administration
    • 6.2.4.By Distribution Channel
    • 6.2.5.By Country
  • 6.3.Europe: Country Analysis
    • 6.3.1.France Skin Hives Treatment Market Outlook
      • 6.3.1.1.Market Size Forecast
        • 6.3.1.1.1.By Value
      • 6.3.1.2.Market Share Forecast
        • 6.3.1.2.1.By Type
        • 6.3.1.2.2.By Treatment
        • 6.3.1.2.3.By Route of Administration
        • 6.3.1.2.4.By Distribution Channel
    • 6.3.2.Germany Skin Hives Treatment Market Outlook
      • 6.3.2.1.Market Size Forecast
        • 6.3.2.1.1.By Value
      • 6.3.2.2.Market Share Forecast
        • 6.3.2.2.1.By Type
        • 6.3.2.2.2.By Treatment
        • 6.3.2.2.3.By Route of Administration
        • 6.3.2.2.4.By Distribution Channel
    • 6.3.3.Spain Skin Hives Treatment Market Outlook
      • 6.3.3.1.Market Size Forecast
        • 6.3.3.1.1.By Value
      • 6.3.3.2.Market Share Forecast
        • 6.3.3.2.1.By Type
        • 6.3.3.2.2.By Treatment
        • 6.3.3.2.3.By Route of Administration
        • 6.3.3.2.4.By Distribution Channel
    • 6.3.4.Italy Skin Hives Treatment Market Outlook
      • 6.3.4.1.Market Size Forecast
        • 6.3.4.1.1.By Value
      • 6.3.4.2.Market Share Forecast
        • 6.3.4.2.1.By Type
        • 6.3.4.2.2.By Treatment
        • 6.3.4.2.3.By Route of Administration
        • 6.3.4.2.4.By Distribution Channel
    • 6.3.5.United Kingdom Skin Hives Treatment Market Outlook
      • 6.3.5.1.Market Size Forecast
        • 6.3.5.1.1.By Value
      • 6.3.5.2.Market Share Forecast
        • 6.3.5.2.1.By Type
        • 6.3.5.2.2.By Treatment
        • 6.3.5.2.3.By Route of Administration
        • 6.3.5.2.4.By Distribution Channel

7.North America Skin Hives Treatment Market Outlook

  • 7.1.Market Size Forecast
    • 7.1.1.By Value
  • 7.2.Market Share Forecast
    • 7.2.1.By Type
    • 7.2.2.By Treatment
    • 7.2.3.By Route of Administration
    • 7.2.4.By Distribution Channel
    • 7.2.5.By Country
  • 7.3.North America: Country Analysis
    • 7.3.1.United States Skin Hives Treatment Market Outlook
      • 7.3.1.1.Market Size Forecast
        • 7.3.1.1.1.By Value
      • 7.3.1.2.Market Share Forecast
        • 7.3.1.2.1.By Type
        • 7.3.1.2.2.By Treatment
        • 7.3.1.2.3.By Route of Administration
        • 7.3.1.2.4.By Distribution Channel
    • 7.3.2.Mexico Skin Hives Treatment Market Outlook
      • 7.3.2.1.Market Size Forecast
        • 7.3.2.1.1.By Value
      • 7.3.2.2.Market Share Forecast
        • 7.3.2.2.1.By Type
        • 7.3.2.2.2.By Treatment
        • 7.3.2.2.3.By Route of Administration
        • 7.3.2.2.4.By Distribution Channel
    • 7.3.3.Canada Skin Hives Treatment Market Outlook
      • 7.3.3.1.Market Size Forecast
        • 7.3.3.1.1.By Value
      • 7.3.3.2.Market Share Forecast
        • 7.3.3.2.1.By Type
        • 7.3.3.2.2.By Treatment
        • 7.3.3.2.3.By Route of Administration
        • 7.3.3.2.4.By Distribution Channel

8.South America Skin Hives Treatment Market Outlook

  • 8.1.Market Size Forecast
    • 8.1.1.By Value
  • 8.2.Market Share Forecast
    • 8.2.1.By Type
    • 8.2.2.By Treatment
    • 8.2.3.By Route of Administration
    • 8.2.4.By Distribution Channel
    • 8.2.5.By Country
  • 8.3.South America: Country Analysis
    • 8.3.1.Brazil Skin Hives Treatment Market Outlook
      • 8.3.1.1.Market Size Forecast
        • 8.3.1.1.1.By Value
      • 8.3.1.2.Market Share Forecast
        • 8.3.1.2.1.By Type
        • 8.3.1.2.2.By Treatment
        • 8.3.1.2.3.By Route of Administration
        • 8.3.1.2.4.By Distribution Channel
    • 8.3.2.Argentina Skin Hives Treatment Market Outlook
      • 8.3.2.1.Market Size Forecast
        • 8.3.2.1.1.By Value
      • 8.3.2.2.Market Share Forecast
        • 8.3.2.2.1.By Type
        • 8.3.2.2.2.By Treatment
        • 8.3.2.2.3.By Route of Administration
        • 8.3.2.2.4.By Distribution Channel
    • 8.3.3.Colombia Skin Hives Treatment Market Outlook
      • 8.3.3.1.Market Size Forecast
        • 8.3.3.1.1.By Value
      • 8.3.3.2.Market Share Forecast
        • 8.3.3.2.1.By Type
        • 8.3.3.2.2.By Treatment
        • 8.3.3.2.3.By Route of Administration
        • 8.3.3.2.4.By Distribution Channel

9.Middle East and Africa Skin Hives Treatment Market Outlook

  • 9.1.Market Size Forecast
    • 9.1.1.By Value
  • 9.2.Market Share Forecast
    • 9.2.1.By Type
    • 9.2.2.By Treatment
    • 9.2.3.By Route of Administration
    • 9.2.4.By Distribution Channel
    • 9.2.5.By Country
  • 9.3.MEA: Country Analysis
    • 9.3.1.South Africa Skin Hives Treatment Market Outlook
      • 9.3.1.1.Market Size Forecast
        • 9.3.1.1.1.By Value
      • 9.3.1.2.Market Share Forecast
        • 9.3.1.2.1.By Type
        • 9.3.1.2.2.By Treatment
        • 9.3.1.2.3.By Route of Administration
        • 9.3.1.2.4.By Distribution Channel
    • 9.3.2.Saudi Arabia Skin Hives Treatment Market Outlook
      • 9.3.2.1.Market Size Forecast
        • 9.3.2.1.1.By Value
      • 9.3.2.2.Market Share Forecast
        • 9.3.2.2.1.By Type
        • 9.3.2.2.2.By Treatment
        • 9.3.2.2.3.By Distribution Channel
    • 9.3.3.UAE Skin Hives Treatment Market Outlook
      • 9.3.3.1.Market Size Forecast
        • 9.3.3.1.1.By Value
      • 9.3.3.2.Market Share Forecast
        • 9.3.3.2.1.By Type
        • 9.3.3.2.2.By Treatment
        • 9.3.3.2.3.By Route of Administration
        • 9.3.3.2.4.By Distribution Channel

10.Market Dynamics

  • 10.1.Drivers
  • 10.2.Challenges

11.Market Trends Developments

  • 11.1.Recent Developments
  • 11.2.Product Launches
  • 11.3.Mergers Acquisitions

12.Global Skin Hives Treatment Market: SWOT Analysis

13.Porter's Five Forces Analysis

  • 13.1.Competition in the Industry
  • 13.2.Potential of New Entrants
  • 13.3.Power of Suppliers
  • 13.4.Power of Customers
  • 13.5.Threat of Substitute Product

14.Competitive Landscape

  • 14.1.Otsuka Holdings Co., Ltd
      • 14.1.1.1.Business Overview
      • 14.1.1.2.Company Snapshot
      • 14.1.1.3.Product Services
      • 14.1.1.4.Financials (In case of listed)
      • 14.1.1.5.Recent Developments
      • 14.1.1.6.SWOT Analysis
  • 14.2.Taiho Pharmaceutical Co., Ltd.
  • 14.3.Amneal Pharmaceuticals LLC
  • 14.4.Galderma SA
  • 14.5.F. Hoffmann-La Roche AG
  • 14.6.Novartis AG
  • 14.7.Dr. Reddy's Laboratories, Ltd.
  • 14.8.Glenmark Pharmaceuticals Ltd.
  • 14.9.Sanofi SA

15.Strategic Recommendations

16.About Us Disclaimer